BRIEF published on 12/16/2025 at 21:23, 2 days 3 hours ago ABIONYX Pharma Announces €1.8 Million Capital Increase Capital Increase Subscription Rights Euronext Listing ABIONYX Pharma Financial Visibility
BRIEF published on 12/16/2025 at 21:23, 2 days 3 hours ago ABIONYX Pharma Annonce une Augmentation de Capital Augmentation De Capital Biopharmaceutique Levée De Fonds ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 2 days 3 hours ago ABIONYX Pharma Announces a Capital Increase Fundraising Capital Increase Biopharmaceutical ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 2 days 3 hours ago ABIONYX Pharma annonce une augmentation de capital de 1,8 million d'euros. Augmentation De Capital Cotation Euronext Visibilité Financière ABIONYX Pharma Droits D'abonnement
PRESS RELEASE published on 12/16/2025 at 21:18, 2 days 3 hours ago Informations privilégiées / Autres communiqués ABIONYX Pharma lance une augmentation de capital de 1,8M€ avec suppression du droit préférentiel de souscription à 3,10 euros par action et extension de la visibilité jusqu'à fin 2026 Augmentation De Capital Droit Préférentiel De Souscription ABIONYX Pharma Visibilité 3,10 Euros
PRESS RELEASE published on 12/16/2025 at 21:18, 2 days 3 hours ago Inside Information / Other news releases ABIONYX Pharma launches €1.8m capital increase with removal of preferential subscription rights, subscription price at 3.10 euros for new shares, extending financial visibility until 2026 Capital Increase Biopharma Preferential Subscription Rights ABIONYX Pharma Financial Visibility
BRIEF published on 12/05/2025 at 18:05, 13 days 6 hours ago ABIONYX Reports Monthly Voting Rights and Share Data Euronext Paris Share Capital Voting Rights AMF Regulations ABIONYX Pharma
BRIEF published on 12/05/2025 at 18:05, 13 days 6 hours ago ABIONYX publie des données mensuelles sur les droits de vote et les actions Euronext Paris Capital Social Droit De Vote ABIONYX Pharma Règlementation De L'AMF
PRESS RELEASE published on 12/05/2025 at 18:00, 13 days 6 hours ago Inside Information / Other news releases ABIONYX Pharma discloses monthly statement of total voting rights and shares as per French regulations. Company focused on innovative medicines in rare diseases Shares French Regulations Total Voting Rights ABIONYX Pharma Innovative Medicines
BRIEF published on 11/25/2025 at 18:38, 23 days 5 hours ago ABIONYX Pharma publie ses prévisions d'activité pour le troisième trimestre 2025 Mise À Jour Financière Revenu ABIONYX Pharma 3e Trimestre 2025 Recherche Sur La Septicémie
Published on 12/19/2025 at 00:00, 35 minutes ago LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
Published on 12/18/2025 at 23:10, 1 hour 25 minutes ago Air T, Inc. Announces Closing of Regional Express Acquisition
Published on 12/18/2025 at 23:05, 1 hour 30 minutes ago BlackBerry Reports Third Quarter Fiscal Year 2026 Results
Published on 12/18/2025 at 22:45, 1 hour 50 minutes ago Stabilis Solutions Announces Multi-Year Marine Bunkering Agreement with Carnival Coprporation at Proposed Galveston LNG Liquefaction Facility
Published on 12/18/2025 at 22:05, 2 hours 30 minutes ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology
Published on 12/18/2025 at 22:05, 2 hours 30 minutes ago Abivax to be Added to Nasdaq Biotechnology Index
Published on 12/18/2025 at 20:09, 4 hours 26 minutes ago EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond
Published on 12/18/2025 at 19:30, 5 hours 5 minutes ago Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES DANS LE CADRE DE L’OFFRE PUBLIQUE DE RETRAIT
Published on 12/18/2025 at 19:30, 5 hours 5 minutes ago Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES , NOTAMMENT JURIDIQUES, FINANCIERE DE PHAST INVEST
Published on 12/18/2025 at 18:30, 6 hours 5 minutes ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Published on 12/18/2025 at 18:30, 6 hours 5 minutes ago Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde
Published on 12/18/2025 at 17:45, 6 hours 50 minutes ago Cie du Bois Sauvage: Vernietiging eigen aandelen
Published on 12/18/2025 at 17:45, 6 hours 50 minutes ago Damartex réaffirme son éligibilité au PEA-PME
Published on 12/18/2025 at 17:45, 6 hours 50 minutes ago Cie du Bois Sauvage : Cancellation of own shares
